FLT3 and acute myeloid leukemia: FLT3-ITD (FLT3 tyrosine kinase receptor) triggers downstream pathways such as STAT5, PI3K/AKT, and RAS/MAPK, which are linked to the higher levels of ROS in AML patients [287].